Navigating the Evolving Regulatory Landscape

On May 1, 2025, BioPortUSA will partner with Global Regulatory Services (GRS) to present a joint webinar focused on recent shifts in regulatory frameworks across the United States and European Union. This timely session aims to separate fact from fiction, bringing clarity to a landscape clouded by conflicting media narratives and speculation.

With increasing pressure on global regulatory bodies and new guidance emerging under the current U.S. administration, the need for reliable insight has never been greater. The webinar will provide attendees with up-to-date information on critical changes impacting market access, compliance, and approval pathways in both regions.

“I’m thrilled that Greer Deal, CEO of Global Regulatory Services, has invited BioPortUSA and Michele Bonn to share the virtual stage,” said Mark Lesselroth, CEO of BioPortUSA. “With so much misinformation circulating in the mainstream media, this is an opportunity to bring clarity and credible analysis to an industry that depends on regulatory certainty.”

Attendees will gain a deeper understanding of how these evolving regulations could affect their commercialization strategies and what steps they can take to stay ahead. The webinar is open to medical technology professionals, regulatory affairs teams, and international companies seeking to enter or expand within the U.S. and EU healthcare markets.

Registration

For those interested in attending, please register at the link below. Attendance is free.

Register Now